Birmingham Medical School, University of Birmingham, Birmingham, United Kingdom.
Department of Dermatology, Aalborg University Hospital, Aalborg, Denmark.
Dermatol Surg. 2021 Mar 1;47(3):e66-e70. doi: 10.1097/DSS.0000000000002879.
5-fluorouracil (5-FU) is widely used for treatment of malignant and premalignant skin cancers; however, its use in other common cutaneous conditions has been less widely reported.
We investigated the off-label uses of 5-FU beyond malignant and premalignant skin disease.
We conducted a literature review searching multiple databases to evaluate the evidence for the off-label uses of 5-FU. The level of evidence was evaluated and selected accordingly listing the studies with the highest level of evidence first using the Oxford Centre of Evidence-Based Medicine 2011 guidance.
We found underlying evidence to support the use of 5-FU for a wide range of noncancerous cutaneous indications including scarring (keloid, hypertrophic), pigmentary disorders (vitiligo, idiopathic guttate hypomelanosis), cutaneous infections (viral warts, molluscum contagiosum), inflammatory dermatoses (Darier's disease, Hailey-Hailey disease and sarcoidosis), and cosmetic indications (photoaging, treatment of filler nodules and granulomas).
In selected patients, 5-FU can be as effective as more established treatments, with fewer side-effects.
5-氟尿嘧啶(5-FU)广泛用于治疗恶性和癌前皮肤癌;然而,其在其他常见皮肤疾病中的应用报道较少。
我们研究了 5-FU 在恶性和癌前皮肤疾病以外的标签外用途。
我们进行了文献回顾,搜索了多个数据库,以评估 5-FU 的标签外用途的证据。根据牛津循证医学中心 2011 年的指导,我们评估并选择了证据水平,并按证据水平最高的研究进行了列出。
我们发现有证据支持 5-FU 用于多种非癌性皮肤疾病,包括瘢痕(瘢痕疙瘩、肥厚性)、色素障碍(白癜风、特发性点状色素减少症)、皮肤感染(病毒性疣、传染性软疣)、炎症性皮肤病(大疱性表皮松解症、Hailey-Hailey 病和结节病)和美容适应症(光老化、填充物结节和肉芽肿的治疗)。
在选择的患者中,5-FU 可能与更成熟的治疗方法一样有效,且副作用更少。